Immune cells, such as tumor-associated macrophages (TAMs), significantly contribute to lymphangiogenesis by producing VEGF-C, which binds to VEGFR-3, promoting endothelial cell proliferation and tumor-induced lymphangiogenesis via PI3K/Akt and MEK/ERK signaling pathways [45]. The gene discussed is FLT4; the disease is neoplasm.